98 related articles for article (PubMed ID: 7200364)
1. Stimulation of the plasminogen activator activity of human synovial fibroblasts by retinoids.
Hamilton JA
Arthritis Rheum; 1982 Apr; 25(4):432-40. PubMed ID: 7200364
[TBL] [Abstract][Full Text] [Related]
2. Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids.
Hamilton JH; Bootes A; Phillips PE; Slywka J
Arthritis Rheum; 1981 Oct; 24(10):1296-303. PubMed ID: 7197936
[TBL] [Abstract][Full Text] [Related]
3. Retinoids and synovial factor(s) stimulate the production of plasminogen activator by cultured human chondrocytes. A possible role for plasminogen activator in the resorption of cartilage in vitro.
Meats JE; Elford PR; Bunning RA; Russell RG
Biochim Biophys Acta; 1985 Jan; 838(1):161-9. PubMed ID: 3917688
[TBL] [Abstract][Full Text] [Related]
4. Modulation of urokinase-type plasminogen activator messenger RNA levels in human synovial fibroblasts by interleukin-1, retinoic acid, and a glucocorticoid.
Vitti G; Hamilton JA
Arthritis Rheum; 1988 Aug; 31(8):1046-51. PubMed ID: 3136776
[TBL] [Abstract][Full Text] [Related]
5. Effects of all-trans-retinoic acid (retinoic acid) and 4-hydroxyphenylretinamide on synovial cells and articular cartilage.
Brinckerhoff CE; Nagase H; Nagel JE; Harris ED
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):591-602. PubMed ID: 6279710
[TBL] [Abstract][Full Text] [Related]
6. Synovial cell activation. Studies on the mechanism of action of synovial activator activity.
Hamilton JA
J Rheumatol; 1983 Dec; 10(6):872-80. PubMed ID: 6420560
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.
Hamilton JA; Piccoli DS; Leizer T; Butler DM; Croatto M; Royston AK
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7180-4. PubMed ID: 1908092
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.
Hamilton JA; Slywka J
J Immunol; 1981 Mar; 126(3):851-5. PubMed ID: 6161965
[TBL] [Abstract][Full Text] [Related]
9. Effects of retinoids on normal and neoplastic human cells cultured in vitro.
Wilson EL; Dowdle EB
Cancer Res; 1980 Dec; 40(12):4817-20. PubMed ID: 7192177
[TBL] [Abstract][Full Text] [Related]
10. The stimulation of human synovial fibroblast plasminogen activator activity. Involvement of cyclic AMP and cyclooxygenase products.
Hamilton JA; Leizer T; Lingelbach SR
Biochim Biophys Acta; 1986 Apr; 886(2):195-202. PubMed ID: 2421780
[TBL] [Abstract][Full Text] [Related]
11. Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.
Hamilton JA; Cheung D; Filonzi EL; Piccoli DS; Wojta J; Gallichio M; McGrath K; Last K
Arthritis Rheum; 1992 Dec; 35(12):1526-34. PubMed ID: 1472130
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue activating peptide III. Induction of synthesis and secretion of plasminogen activator by synovial fibroblasts.
Ragsdale CG; Castor CW; Roberts DJ; Swartz KH
Arthritis Rheum; 1984 Jun; 27(6):663-7. PubMed ID: 6539601
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator in chick fibroblasts: induction of synthesis by retinoic acid; synergism with viral transformation and phorbol ester.
Wilson EL; Reich E
Cell; 1978 Oct; 15(2):385-92. PubMed ID: 214237
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor alpha, tumor necrosis factor beta (lymphotoxin), interleukin-1 alpha, and interleukin-1 beta.
Butler DM; Vitti GF; Leizer T; Hamilton JA
Arthritis Rheum; 1988 Oct; 31(10):1281-9. PubMed ID: 3140820
[TBL] [Abstract][Full Text] [Related]
15. Diverse morphological responses of normal human synovial fibroblasts to mononuclear leukocyte products: relationship to prostaglandin production and plasminogen activator activities, and comparison with the effects of purified interleukin 1.
Clarris BJ; Leizer T; Fraser JR; Hamilton JA
Rheumatol Int; 1987; 7(1):35-41. PubMed ID: 3495854
[TBL] [Abstract][Full Text] [Related]
16. Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium.
Andrews HJ; Cawston TE; Hazleman BL
Biochim Biophys Acta; 1990 Jan; 1051(1):84-93. PubMed ID: 2297544
[TBL] [Abstract][Full Text] [Related]
17. Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells.
Golds EE; Ciosek CP; Hamilton JA
Arthritis Rheum; 1983 Jan; 26(1):15-21. PubMed ID: 6297507
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator activity of rheumatoid and nonrheumatoid synovial fibroblasts.
Hamilton JA
J Rheumatol; 1982; 9(6):834-42. PubMed ID: 6891721
[TBL] [Abstract][Full Text] [Related]
19. Human synovial fibroblasts produce urokinase-type plasminogen activator.
Medcalf RL; Hamilton JA
Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
[TBL] [Abstract][Full Text] [Related]
20. Responses of human synovial fibroblasts to mononuclear cell factors and retinoic acid.
Hamilton JA
Agents Actions Suppl; 1986; 18():47-54. PubMed ID: 2425604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
